Convergent Dental Secures $50M in Funding

Facebook X LinkedIn Email
WALTHAM, Mass., May 2, 2023 — Dental technology company Convergent Dental has entered into a new credit facility of $40 million with Trinity Capital. The company has drawn $20 million at closing and has the option to draw an additional $20 million, subject to the conditions under the agreement.

The company has also received $10 million in equity financing led by existing investors Arboretum Ventures and Gund Investment, including $5 million of new equity and $5 million of existing investor notes converted to equity at the close.

Convergent Dental’s flagship product is the Solea All-Tissue Dental Laser, an FDA-approved CO2 dental laser that allows dentists to perform virtually anesthesia-free, blood-free, and pain-free procedures.

Published: May 2023
BusinessLasersCO2carbon dioxideConvergent DentalBiophotonicsdentaldentistryfundingfinancingAmericas

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.